Skip to Content
Interactive Textbook on Clinical Symptom Research Logo

Home Button

A Study of Insomnia and Sleep Loss
Author Bio
Part I
Part II
Using a Stress Framework
Protocol Design
SNS Activation
Sleep Misperception and Loss
Insomnia and Performance Testing
Insomnia and Emotional Arousal
Yoked Control Design
Currently selected section: Effects of Sleep Loss
Insomnia and Somatic Symptoms
Conclusion
 
 
 
 


Chapter 15: Challenges to the Study of Insomnia and Sleep Loss: Probing the Effects of Sleep Loss in Insomnia
        

In the further pursuit of evidence, Dr. Bonnet's team decided to see whether worsening sleep loss in people with psychophysiologic insomnia would intensify previously observed insomnia correlates. The subjects came to the laboratory for 10 nights. From two baseline nights, the usual nightly sleep duration was determined and a calculation of 80% of baseline determined and divided by four. On the next seven nights, subjects were awakened to prevent sleep duration from exceeding 80% of the usual amount in each quarter of the night.

Bonnet and his colleagues found that: 1) these insomnia subjects displayed no significant change in subjective anxiety/tension (POMS) or body temperature, and 2) they had decreased (as opposed to increased) whole metabolic rate following nights of particularly poor sleep. Subjects showed reduced MSLT values, indicating more sleepiness. It was concluded that the features of primary insomnia displayed by these subjects were not exaggerated by worsened sleep loss and, therefore, are probably not related to sleep loss per se.

Besides mimicking a psychophysiological-type insomnia sleep pattern, Bonnet and colleagues have also mimicked an exaggerated stress arousal/activation pattern in people with no sleep problems using doses of caffeine as a stimulant. They saw support for the hypothesis that excess stress arousal/activation is the source of the selected features of insomnia. The features across conditions are compared in the following chart (Bonnet et al., 1996).

Table 3.8.1: Dr. Bonnet's Studies
Features Yoked Control - Derived Insomnia Primary Insomnia - psychophysiological-type Stimulant-induced Hyperaroused/
Activated
Tension/anxiety (POMS)
Decreased
Increased
Increased
Vigor (POMS)
Decreased
Decreased
Decreased
Sleepiness (MSLT)
Increased
Equal or Decreased
Equal or Decreased
Metabolic Rate
Increased (PM) Decreased (AM)
Increased
Increased
Body Temperature
Decreased
Increased
Increased

These comparative data were used to support the contention that secondary symptoms in patients with insomnia, and perhaps the poor sleep pattern itself, occur through central nervous system hyperarousal and not to sleep loss per se.

The relationship of the symptoms of fatigue and tiredness to insomnia or poor sleep raises the issue of distinguishing between sources of fatigue. Insomnia is a concurrent symptom in many disease/illness conditions, particularly those involving pain and fatigue. Tiredness or sleepiness (often referred to as fatigue) attributable to sleep disruption or loss is reported by large numbers of people in their everyday lives. Fatigue in this context is related to the tendency to fall asleep and the effort needed to resist it. This form of tiredness should be distinguished from the hallmark symptom of fatigue concurrent with many rheumatic, autoimmune, and mysterious conditions such as chronic fatigue syndrome and fibromyalgia. In these conditions, fatigue is expressed as a profound lack of energy or exhaustion, fatigability upon exertion and not sleepiness. Almost ubiquitously, disturbed sleep or reports of 'unrefreshing' sleep is evident in such conditions. In many situations, it can be unclear as to whether fatigue is primary in contributing to sleep disturbance or whether sleep disturbance is primary in contributing to fatigue or tiredness.

Page 30 of 33
      Previous Section